Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre Proof-of-performance Clinical Study to Validate Blood-based Biomarker Candidates for the Diagnosis of Alzheimer's Disease

NCT03030586 is registered in ClinicalTrials.gov with Amoneta Diagnostics SAS as lead sponsor.

NCT NCT03030586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03030586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre Proof-of-performance Clinical Study to Validate Blood-based Biomarker Candidates for the Diagnosis of Alzheimer's Disease
Lead sponsor
Amoneta Diagnostics SAS
Phase
Observational
Overall status
Completed
Start date
September 1, 2016
Completion date
June 30, 2023
Enrollment
821 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease (ad), corticobasal degeneration (cbd), dementia with lewy bodies (dlb), frontotemporal lobar degeneration, parkinson disease dementia (pdd), progressive supranuclear palsy (psp)